Home · Services · GeneSight Testing
GeneSight testing is a cheek-swab genetic test that shows how your body may process certain psychiatric medications — information Evans Duah, PMHNP-BC, uses alongside your history and symptoms, not in place of them. Available at the Providence office, or by telehealth across Rhode Island, Massachusetts, Arizona, and Colorado.
The test itself
GeneSight is a pharmacogenomic test — it analyzes genetic variants that affect how your body metabolizes certain drugs, not whether you have a particular condition. A simple cheek swab, taken in the office or at home with a kit, is sent to a lab, and results are typically back in about 3 days.
The report doesn’t diagnose anything or predict which medication will definitely work. It classifies more than 60 medications used for depression, anxiety, ADHD, and other psychiatric conditions into three color-coded groups — green (use as directed), yellow (moderate gene-drug interaction), and red (significant gene-drug interaction) — based on your genetics, and explicitly does not test for drug-drug interactions, allergies, or diagnosis.
The evidence
Short answer: it changes what gets prescribed more reliably than it changes how patients actually feel. The largest randomized trial done on it — the VA’s PRIME Care study of 1,944 patients with major depressive disorder — found that patients whose care was guided by GeneSight results were far more likely to be started on a medication with no predicted gene-drug interaction (45%) than patients in usual care (18%). But remission of depression symptoms was only modestly higher across the full 24 weeks (a 2.8-percentage-point difference) and wasn’t statistically significant anymore by the final 24-week assessment.
“One thing about GeneSight testing that can make a difference in mental health care is personalization: it can show how your genes affect the way your body processes certain psychiatric medications, helping your prescriber make better-informed medication and dosing choices rather than relying only on trial and error. For example, results may flag a medication that your body processes differently, prompting consideration of a dose adjustment or another option — that’s its main practical value, not identifying a guaranteed ‘best’ medication. The important limitation: GeneSight cannot promise that a medication will relieve your symptoms. In a large study, genetic testing reduced prescriptions with predicted gene-drug interactions, but improvements in depression remission were small and did not persist at the final assessment. It’s a tool to support clinical judgment, not replace it.”
Evans Duah, PMHNP-BC
That’s the honest version: GeneSight is useful information, not an answer key.
Cost
Coverage depends on your plan, but most patients pay far less than the test’s list price. 98% of patients pay $330 or less, and it’s typically $0 out of pocket for people on Medicare Part B, Medicare Advantage, or Medicaid. If your estimated cost would run higher than $330, the testing lab contacts you before processing the sample to discuss financial assistance or an interest-free payment plan — you’re not billed first and informed after.
| Coverage situation | Typical out-of-pocket cost |
|---|---|
| Medicare Part B, Medicare Advantage, or Medicaid | $0, typically |
| Most other insurance plans | $330 or less, for 98% of patients |
| Cost estimated above $330 | Contacted beforehand for financial assistance or a payment plan |
| Uninsured | Self-pay rate available by request when you call |
Getting started
You don’t need to request GeneSight testing specifically before your first visit — Evans will discuss whether it’s a fit for you based on your history, especially if a prior medication caused side effects or didn’t help. If it makes sense, he orders it directly; you can’t order it yourself without a prescribing clinician.
Once ordered, the cheek swab happens either in the Providence office or at home with a mailed kit, and results typically come back in about three days. Evans reviews the report with you at your next appointment and factors it into — not instead of — the medication conversation you’re already having.
Coverage
The GeneSight report covers medications commonly prescribed for depression, anxiety, ADHD, and related conditions, sorting each into a green, yellow, or red category based on your genetics. It’s a tool for the medication conversation, not a replacement for it — the same genetic testing for depression medication that shows a drug in the “green” category still has to actually work for you clinically, and Evans checks that the same way he always does: by asking what you took, how consistently, and what changed.
Is it for you
GeneSight tends to be most useful for people who’ve already tried a medication that caused side effects, didn’t seem to help, or raised a “is it the drug or the dose” question — not as a first step for everyone starting treatment. Psychiatric genetic testing isn’t required to be seen at Lampstand, and it isn’t a substitute for the evaluation itself; it’s one more piece of information layered onto a conversation that was already happening.
If a prior medication trial left you wondering whether the problem was the drug, the dose, or something else entirely, that’s the conversation to start.
In an emergency, do not use this website. If you or someone else is in immediate danger, call or text 988 (Suicide & Crisis Lifeline) or go to the nearest emergency room.

Get in touch
GeneSight testing is one part of Lampstand Behavioral Health’s full range of psychiatric services, available in person in Providence, RI, and by telehealth across Rhode Island, Massachusetts, Arizona, and Colorado.